These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The use of psychotropic drugs in epilepsy: what every neurologist should know. Kanner AM Semin Neurol; 2008 Jul; 28(3):379-88. PubMed ID: 18777484 [TBL] [Abstract][Full Text] [Related]
26. An update on adolescent psychopharmacology. Katic A; Steingard RJ; Schmidt C Adolesc Med; 1998 Jun; 9(2):217-28. PubMed ID: 10961231 [TBL] [Abstract][Full Text] [Related]
27. Psychopharmacology of disorders in children. Sylvester C Psychiatr Clin North Am; 1993 Dec; 16(4):779-91. PubMed ID: 8309812 [TBL] [Abstract][Full Text] [Related]
28. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review. Erenberg G Semin Pediatr Neurol; 2005 Dec; 12(4):217-21. PubMed ID: 16780292 [TBL] [Abstract][Full Text] [Related]
29. Management of Adverse Effects of Psychotropic Medications. Romba C; Perez-Reisler M Pediatr Ann; 2020 Oct; 49(10):e431-e435. PubMed ID: 33034658 [TBL] [Abstract][Full Text] [Related]
30. [Antipsychotic treatment in childhood and adolescence: a bibliographical review]. García López MM Actas Esp Psiquiatr; 2001; 29(1):41-6. PubMed ID: 11333518 [TBL] [Abstract][Full Text] [Related]
31. Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders. Weller EB; Rowan A; Elia J; Weller RA J Clin Psychiatry; 1999; 60 Suppl 15():5-11. PubMed ID: 10418807 [TBL] [Abstract][Full Text] [Related]
32. Management of psychopharmacologic agents in children and adolescents. Carlson GA; Ranade L; Qadir A Psychiatr Q; 1992; 63(4):391-411. PubMed ID: 1361998 [No Abstract] [Full Text] [Related]
34. New developments in pediatric psychopharmacology. Gualtieri CT; Golden RN; Fahs JJ J Dev Behav Pediatr; 1983 Sep; 4(3):202-9. PubMed ID: 6355189 [TBL] [Abstract][Full Text] [Related]
35. Drugs for psychiatric disorders. Med Lett Drugs Ther; 1980 Sep; 22(19):77-84. PubMed ID: 6106886 [No Abstract] [Full Text] [Related]
36. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Research Units on Pediatric Psychopharmacology Autism Network Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814 [TBL] [Abstract][Full Text] [Related]
37. Psychopharmacology of autism spectrum disorder: evidence and practice. Siegel M Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):957-73. PubMed ID: 23040909 [TBL] [Abstract][Full Text] [Related]
38. Psychopharmacology of autism spectrum disorders: a selective review. Mohiuddin S; Ghaziuddin M Autism; 2013 Nov; 17(6):645-54. PubMed ID: 22892891 [TBL] [Abstract][Full Text] [Related]
39. [Psychotropic drugs for children]. Nissen G MMW Munch Med Wochenschr; 1981 Feb; 123(7):245-6. PubMed ID: 6780896 [No Abstract] [Full Text] [Related]